MLTO Medirect Latino Inc (CE)

MEDirect Latino Inc. (OTC:MLTO) http://www.medirectlatino.org, announced today, the selection of Vertical Communications, Inc.'s TeleVantage 6, to provide advanced comprehensive call center support of the Company's in house customer care center, with integrated phone and computer systems to take advantage of the shift from proprietary to open systems that are transforming the telecommunications industry and defining customer care. MEDirect Latino is a rapidly growing, 3-year-old, federally licensed national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. The Company's customer care center provides a culturally specific and demographically focused training program for its customer care representatives to be able to serve the targeted healthcare market. TeleVantage software and hardware integrated systems provides a complete, cost-effective communications solution by integrating into one unit, sophisticated voice services and high-performance data networking. In addition, the system streamlines communications with new applications and services that take advantage of the convergence of voice and data increasing capacity of networks and providing a migration path to voice over IP (VoIP). This system integrates voice and data traffic over a single T1 line, eliminating the need for multiple voice lines and providing greater bandwidth at a competitive price. "The TeleVantage solution provides a scalable, state-of-the-art, technical fit for our multi-tired customer intake, customer service platform and database management systems," stated Mr. Carlos Soler, MEDirect Latino, Vice-President - Customer Care. "Healthcare is a business of personal service, and demographically the MEDirect Latino customer requires personal individualized attention to their needs. Employing the TeleVantage system into our network allows my customer care representatives to make appointment closes tailored to the customers needs. The choice of TeleVantage provides an important complimentary component to a very complex structure of customer service. MEDirect Latino continues to define the standard in the Hispanic Medicare reimbursable healthcare industry," Mr. Soler further stated. The Company will host a conference call update with brokers, fund managers and investors to be scheduled for August. This call will discuss material events which are occurring in the month of July and will include results from its launch in Puerto Rico, national advertising roll-out and co-branded manufacturing agreements. About MEDirect Latino MEDirect Latino (OTC:MLTO) - http://www.medirectlatino.org - is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the US Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure. The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion). Forward-Looking Statements: Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; the Company will appropriately inform the public.